Durable response to pembrolizumab in microsatellite instability‐high advanced adrenocortical carcinoma

INTRODUCTION: Advanced adrenocortical carcinoma has a poor prognosis and is treated with chemotherapy that includes mitotane with etoposide, doxorubicin, and cisplatin as first‐line therapy. However, second‐line therapy has not been determined yet. Pembrolizumab has been approved for high microsatel...

Descripción completa

Detalles Bibliográficos
Autores principales: Senda, Masaya, Hashimoto, Kohei, Shindo, Tetsuya, Kobayashi, Ko, Tanaka, Toshiaki, Masumori, Naoya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622203/
https://www.ncbi.nlm.nih.gov/pubmed/37928286
http://dx.doi.org/10.1002/iju5.12628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622203/
https://www.ncbi.nlm.nih.gov/pubmed/37928286
http://dx.doi.org/10.1002/iju5.12628

Ejemplares similares